US 9556144
Compound as WNT signaling inhibitor, composition, and use thereof
granted A61PA61P1/16A61P11/00
Quick answer
US patent 9556144 (Compound as WNT signaling inhibitor, composition, and use thereof) held by Curegenix, Inc. expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Curegenix, Inc.
- Grant date
- Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P13/12, A61P17/00